Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users

Background Injecting drug users (IDUs) are a major and most important risk factor for rising hepatitis C virus (HCV) prevalence in Iran. Objectives The objective of this study was to determine the effectiveness of methadone maintenance treatment (MMT) in prevention of HCV infection transmission among IDUs. Patients and Methods A mathematical modeling has been used to estimate number of HCV infections averted. The input parameters used in the model were collected by self-reported method from 259 IDUs before registering and one year after MMT. Nonparametric statistical tests have been used to compare risky injecting and sexual behaviors among IDUs before and after participating in MMT program. Deterministic sensitivity analyses were done to show the effects of parameters’ uncertainty on outcome. Results Of the 259 participants, 98.4% (255) were men, the mean age ± SD was 33.1 ± 7.58 years and HCV prevalence was 50%. The studied IDUs reported lower rate of risky injecting and sexual behavior after participation in MMT program. The cumulative incidence of HCV per 100 IDUs due to sharing injection and unsafe sexual contact with MMT program were 13.84 (95% CI: 6.17 -21.51), 0.0003 (0.0001 - 0.0005) and without it 36.48 (25.84 - 47.11) and 0.0004 (0.0002-0.0006) respectively. Conclusions The MMT program is an effective intervention to prevent HCV infection transmission, although it is essential to compare its effectiveness with other interventions before implementing it in nationwide.

• Publication year

  2013

• Venue

  Hepatitis Monthly

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5812/hepatmon.12411PMID 24069039PMCID 3782738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study

  2013cited by this paper
• Mitigating the risk of HIV infection with opioid substitution treatment.

  2013cited by this paper
• Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence

  2013cited by this paper
• RNA Interference: A Promising Approach for the Treatment of Viral Hepatitis

  2012cited by this paper
• Modeling of human immunodeficiency virus modes of transmission in Iran.

  2012influential reference
• Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran

  2012cited by this paper
• Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors

  2012cited by this paper
• Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

  2011cited by this paper
• Oral substitution treatment of injecting opioid users for prevention of HIV infection.

  2011cited by this paper
• Hepatitis C and pulmonary fibrosis

  2011cited by this paper
• The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

  2011cited by this paper
• A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.

  2011cited by this paper
• Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors

  2011cited by this paper
• Seroprevalence of hepatitis C virus: the first population-based study from Iran.

  2010cited by this paper
• Title Prevalence and Correlates of Hepatitis C Infection among Male Injection Drug Users in Detention

  2009cited by this paper
• Epidemiology of hepatitis C in Iran and the world.

  2009cited by this paper
• Hepatitis C infection in the general population of Iran: a systematic review.

  2009cited by this paper
• Prevalence and Correlates of Hepatitis C Infection among Male Injection Drug Users in Detention, Tehran, Iran

  2009cited by this paper
• The cost-effectiveness of Vancouver's supervised injection facility

  2008cited by this paper
• Pruritic, serpiginous eruption in a returning traveller

  2008cited by this paper
• Substitution treatment of injecting opioid users for prevention of HIV infection.

  2008cited by this paper
• Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infection: A meta‐analysis and meta‐regression

  2008cited by this paper
• The natural history of chronic hepatitis B

  2007cited by this paper
• Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.

  2007cited by this paper
• Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.

  2007cited by this paper
• The burden of hepatitis C in England

  2007cited by this paper
• Global estimates of prevalence of HCV infection among injecting drug users.

  2007cited by this paper
• The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002

  2006cited by this paper
• Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men.

  2005cited by this paper
• Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.

  2005cited by this paper
• [Sexual transmission of hepatitis C virus].

  2005cited by this paper
• Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France

  2004cited by this paper
• Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China.

  2004cited by this paper
• Effectiveness of condoms in preventing sexually transmitted infections.

  2004cited by this paper
• Taking up the reins

  2003cited by this paper
• Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples

  2003cited by this paper
• Risk of hepatitis C virus transmission following percutaneous exposure in healthcare workers.

  2003cited by this paper
• Condom effectiveness in reducing heterosexual HIV transmission.

  2002cited by this paper
• [Condom effectiveness in reducing heterosexual HIV transmission].

  2002cited by this paper
• Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users.

  2002cited by this paper
• Ambient formaldehyde detection with a laser spectrometer based on difference-frequency generation in PPLN

  2001cited by this paper
• Risk factors for hepatitis C virus infection among street youths.

  2001cited by this paper
• Sexual transmission of hepatitis C virus.

  1999cited by this paper
• Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users.

  1999cited by this paper
• Prevalence of hepatitis C virus infection in the United States.

  1999cited by this paper
• Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.

  1999cited by this paper
• Hepatitis C: the clinical spectrum of the disease.

  1999cited by this paper
• The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

  1999cited by this paper
• [The prevalence of hepatitis C virus infection].

  1998cited by this paper
• Dobson promises extra cash for NHS

  1998cited by this paper
• Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study

  1998cited by this paper
• Gastric adenocarcinoma and kidney transplantation

  1998cited by this paper
• Epidemiology of hepatitis C

  1997cited by this paper
• Methadone maintenance and hepatitis C virus infection among injecting drug users.

  1997cited by this paper
• Hepatitis C: The clinical spectrum of disease

  1997cited by this paper
• The medical status of methadone maintenance patients in treatment for 11-18 years.

  1993cited by this paper
• High-risk sexual behaviors of intravenous drug users in- and out-of-treatment: implications for the spread of HIV infection.

  1992cited by this paper
• Sexual transmission of hepatitis C virus

  1991cited by this paper

• Medications to Treat Opioid Use Disorder.

  2026cites this paper
• A Discrete-Choice Experiment to Assess Patient Preferences for Long-Acting Injectable Treatments in Opioid Use Disorder in Australia, Finland, Germany, and Italy

  2025cites this paper
• Depression and its associated factors among people who use drugs attending the Methadone Treatment Clinic at Tumbi Hospital in Pwani, Tanzania: A cross-sectional study

  2025cites this paper
• Medicaid And Methadone For Opioid Use Disorder: Expanded Coverage Increased Distribution In 10 States, 2019-24.

  2025cites this paper
• Novel Uses of Methadone Under the “72-Hour Rule” to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic

  2024cites this paper
• Hepatitis C Virus Infection in Iran: A Review of Current Prevalence and Preventive Strategies from A Developing Country

  2024cites this paper
• The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder

  2024cites this paper
• Male patients’ preferences for opioid use treatment programs

  2023cites this paper
• Medication for opioid use disorder in the Arab World: A systematic review.

  2022cites this paper
• Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis

  2021cites this paper
• Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule

  2021cites this paper
• Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis

  2021cites this paper
• Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics

  2020cites this paper
• Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program

  2020cites this paper
• Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality

  2020cites this paper
• DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China

  2019cites this paper
• Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction

  2019cites this paper
• Medical complications of opioid use disorder in pregnancy.

  2019influential citation
• The Global State of Harm Reduction in Prisons

  2019cites this paper
• Advantages and Disadvantages of Methadone among Children and Adults: A Systematic Review and Meta-Analysis

  2019influential citation
• Correlation between interleukin-6 levels and methadone maintenance therapy outcomes.

  2019cites this paper
• The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden

  2019cites this paper
• The Evolution of Addiction Treatment and Harm Reduction Programs in Iran: A Chaotic Response or a Synergistic Diversity?

  2019cites this paper
• Gender Differences Among Patients With Hepatitis C Virus Undergoing Rehabilitation Through Methadone Maintenance Treatment

  2018cites this paper
• Paper : Gender Differences Among Patients With Hepatitis C Virus Undergoing Rehabilitation Through Methadone Maintenance Treatment

  2018cites this paper
• Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland’s drug and alcohol services

  2018cites this paper
• Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users

  2018cites this paper
• Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice.

  2018cites this paper
• F ACTORS A SSOCIATED WITH W ILLINGNESS T O P ARTICIPATE IN A P HARMACOLOGIC A DDICTION T REATMENT C LINICAL T

  2017cites this paper
• HIV PREVENTION 2020: A GLOBAL PARTNERSHIP FOR DELIVERY

  2017cites this paper
• Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

  2017cites this paper
• Willingness to Receive Treatment for Hepatitis C among Injecting Drug Users on Methadone Program: Implications for Education and Treatment

  2016cites this paper
• Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs.

  2015cites this paper
• Increasing access to opioid maintenance treatment: the role of primary care in France.

  2015cites this paper
• Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa

  2015cites this paper
• Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.

  2015cites this paper
• The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users.

  2014cites this paper
• HIV among People Who Inject Drugs in the Middle East and North Africa: Systematic Review and Data Synthesis

  2014cites this paper
• Advancing Service Integration in Opioid Treatment Progams for the Care and Treatment of Hepatitis C Infection

  2014cites this paper
• Portraying Persons Who Inject Drugs Recently Infected with Hepatitis C Accessing Antiviral Treatment: A Cluster Analysis

  2014cites this paper
• Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions

  2014cites this paper
• Opioid use, treatment and harm reduction services: the first report from the Persian Gulf region

  2014cites this paper
• Medication Assisted Treatment Guidelines for Opioid Use Disorders MAT Work Group

  2014cites this paper
• The Long-Term Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Among Illicit Drug Users: A Modeling Study

  2014cites this paper